Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	Telmisartan/Ramipril (ONTARGET)
Total, all-cause mortality	Telmisartan (ONTARGET)
Total, all-cause mortality	Ramipril (ONTARGET)
Total, all-cause mortality	Telmisartan (TRANSCEND)
Total, all-cause mortality	Placebo (TRANSCEND)
Total, other adverse events	Telmisartan/Ramipril (ONTARGET)	0	8,502
Total, other adverse events	Telmisartan (ONTARGET)	0	8,542
Total, other adverse events	Ramipril (ONTARGET)	0	8,576
Total, other adverse events	Telmisartan (TRANSCEND)	0	2,954
Total, other adverse events	Placebo (TRANSCEND)	0	2,972
Total, serious adverse events	Telmisartan/Ramipril (ONTARGET)	5,268	8,502
Total, serious adverse events	Telmisartan (ONTARGET)	5,506	8,542
Total, serious adverse events	Ramipril (ONTARGET)	5,375	8,576
Total, serious adverse events	Telmisartan (TRANSCEND)	1,781	2,954
Total, serious adverse events	Placebo (TRANSCEND)	1,830	2,972

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00153101/event-totals